Tamsulosin Medical Valley, 0.4 mg, prolonged-release hard capsules
Tamsulosin hydrochloride
The active substance of Tamsulosin Medical Valley is tamsulosin. Tamsulosin is a selective alpha-1 adrenergic receptor antagonist. It reduces the tension of the smooth muscles of the prostate and urethra, facilitating the flow of urine through the urethra and urination. Additionally, tamsulosin reduces the feeling of urgency to urinate.
Tamsulosin Medical Valley is used in men for the treatment of symptoms of benign prostatic hyperplasia (enlargement of the prostate gland). These symptoms include difficulty urinating (weak stream), urinating in drops, urgency to urinate, and increased frequency of urination both at night and during the day.
Before starting treatment with Tamsulosin Medical Valley, discuss it with your doctor or pharmacist.
Do not use this medicine in children and adolescents under 18 years of age, as it is not effective in this patient group.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take.
Taking Tamsulosin Medical Valley with other medicines in the same group (alpha-1 adrenergic receptor antagonists) may result in unintended low blood pressure.
It is especially important to tell your doctor if you are taking medicines that may reduce the elimination of Tamsulosin Medical Valley from the body (e.g., ketoconazole, erythromycin).
Take the medicine after breakfast or after the first meal of the day.
This does not apply, as Tamsulosin Medical Valley is intended for use in men only.
There have been reports of abnormal ejaculation in men (ejaculation disorders). This means that semen does not flow through the urethra but instead flows back into the bladder (retrograde ejaculation), or the volume of ejaculation is reduced or does not occur. These symptoms are not harmful to the patient.
There is no data on the effect of Tamsulosin Medical Valley on the ability to drive or operate machinery. However, be aware of the possibility of dizziness. In such cases, do not perform tasks that require concentration and attention.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
The recommended dose is one capsule per day, taken after breakfast or after the first meal of the day. Swallow the capsule whole, do not chew or crush it.
Tamsulosin Medical Valley is usually prescribed for long-term use.
The effect on the bladder and urination persists during long-term treatment with Tamsulosin Medical Valley.
Taking too many Tamsulosin Medical Valley capsules may lead to unintended low blood pressure and increased heart rate with a feeling of weakness. If you have taken too many Tamsulosin Medical Valley capsules, contact your doctor immediately.
If you miss a dose of Tamsulosin Medical Valley at the recommended time, you can take it later that day. If you forget to take the medicine on a given day, take the next capsule at the usual time the next day. Do not take a double dose to make up for a missed dose.
If treatment with Tamsulosin Medical Valley is stopped earlier than recommended, the symptoms of the disease may recur. Therefore, take Tamsulosin Medical Valley for as long as your doctor has prescribed, even if the symptoms have disappeared. Stopping treatment should always be discussed with your doctor.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Tamsulosin Medical Valley can cause side effects, although not everybody gets them.
Stop taking the medicine and seek medical help immediately if you experience any of the following allergic reactions:
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 patients)
Not known (frequency cannot be estimated from the available data)
If you are scheduled for cataract surgery and are taking or have taken tamsulosin hydrochloride, the pupil may not dilate properly, and the iris may become floppy during surgery.
In addition to the side effects listed above, the following have also been reported in connection with tamsulosin:
Since these reports come from spontaneous reports from around the world after the marketing of tamsulosin, it is not possible to reliably determine the frequency of these events and the role of tamsulosin hydrochloride in their occurrence.
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
There are no special precautions for storage.
Do not use this medicine after the expiry date stated on the blister, bottle, or carton after "Expiry Date (EXP)". The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Each capsule contains 0.4 mg of tamsulosin hydrochloride.
The other ingredients are:
Pellets: Methacrylic acid - ethyl acrylate copolymer (1:1) dispersion 30% (type A)*, microcrystalline cellulose (type 105), dibutyl sebacate, polysorbate 80
Pellet coating: Methacrylic acid - ethyl acrylate copolymer (1:1) dispersion 30% (type A)*, dibutyl sebacate, polysorbate 80, colloidal silicon dioxide, hydrated
Calcium stearate
Capsule shell: Red iron oxide (E 172), titanium dioxide (E 171), yellow iron oxide (E 172), black iron oxide (E 172), indigo carmine (E 132), gelatin
* The dispersion contains 0.7% sodium lauryl sulfate (Ph. Eur.) and 2.3% Polysorbate 80 (Ph. Eur.) in solid form as an emulsifier.
Tamsulosin Medical Valley is available in the form of hard capsules, approximately 15.6-16.2 mm in length, with an opaque orange body and an olive-green cap.
Tamsulosin Medical Valley is packaged in PVC/PVDC/Aluminum blisters or HDPE bottles, placed in a cardboard box.
PVC/PVDC/Aluminum blisters contain 10, 20, 30, 50, 90, or 100 capsules.
Perforated single-dose blisters of PVC/PVDC/Aluminum contain 10 x 1, 20 x 1, 30 x 1, 50 x 1, 90, or 100 x 1 capsules.
HDPE bottles contain 30, 35, 50, 60, 90, 100, 112, or 200 capsules.
Not all pack sizes may be marketed.
Medical Valley Invest AB
Brädgårdsvägen 28
236 32 Höllviken
Sweden
email: safety@medicalvalley.se
LABORATORIOS LICONSA S.A.
Avda. Miralcampo, Nº 7
Polígono Industrial Miralcampo
19200 Azuqueca de Henares (Guadalajara)
Spain
Denmark
Tamsulosin Medical Valley
Netherlands
Tamsulosine HCl Xiromed 0.4 mg, hard capsules with modified release
Germany
Tamsaxiro 0.4 mg Hartkapsel mit veränderter Wirkstofffreisetzung
Norway
Tamsulosin Medical Valley
Poland
Tamsulosin Medical Valley
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.